enVVeno Medical Corporation announced the promotion of Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer. Dr. Alavi joined enVVeno Medical as Director, Research, Development and Quality in July 2020 and was promoted to Vice President of Research, Development and Quality in January 2021. In his new role as Senior Vice President and Chief Technology Officer, Dr. Alavi will seek to incorporate of innovative technologies such as artificial intelligence and cloud-based computing into our existing product mix, while also preparing our manufacturing and quality departments for commercialization of the VenoValve.

Prior to joining enVVeno Medical, Dr. Alavi was the head of engineering at NaviGate Cardiac Structures Inc., a startup which developed tricuspid heart valve replacement and delivery system devices. This and his previous roles at Medtronic Cardiac and Vascular Group (CVG) and Edwards Lifesciences Center for Advanced Cardiovascular Technology allowed him to use his unparalleled vision, and technical and leadership skills to drive early-stage medical device technologies from conception to commercialization. Dr. Alavi received his doctorate in biomedical engineering from University of California, Irvine where he was trained in one of the most prominent cardiovascular engineering doctoral programs in the US.

His pioneering work in hybrid tissue and implantable medical devices was broadly recognized and given accolades by a number of institutions - such as the American Heart Association. He also holds an M.S. degree in biomedical engineering and a B.S. degree in mechanical engineering.